Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vaccination against hepatitis B]

D Desgrandchamps1, C A Siegrist

  • 1Schweizerische Kommission für Impffragen, Baar.

Sozial- Und Praventivmedizin
|December 2, 1998
PubMed
Summary

Hepatitis B vaccines achieve high seroconversion rates and long-term protection through immunological memory, eliminating the need for antibody testing or booster doses in healthy individuals. These safe vaccines are suitable for universal administration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Successful serology-based intervention to increase protection against vaccine-preventable diseases in liver-transplanted children: a 19-yr review of the Swiss national reference center.

Pediatric transplantation·2011
Same author

[Diagnosis, treatment and prevention of measles].

Revue medicale suisse·2008
Same author

[First glance at the 2007 national immunization plan].

Revue medicale suisse·2007
Same author

Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins.

Vaccine·2006

Area of Science:

  • Immunology
  • Vaccinology
  • Hepatology

Context:

  • Three recombinant HBsAg vaccines for hepatitis B are available in Switzerland.
  • Standard immunization schedules (0,1,6 or 0,1,2,12 months) induce high seroconversion rates.

Purpose:

  • To evaluate the necessity of antibody titer determination and booster doses for hepatitis B vaccination.
  • To assess the long-term protection and safety profile of hepatitis B vaccines.

Summary:

  • Recombinant hepatitis B vaccines induce seroconversion in 95% of individuals.
  • Protection persists beyond antibody detection due to immunological memory, negating the need for boosters.
  • Booster doses are unnecessary even for infants or those with early vaccination schedules.

Impact:

  • Hepatitis B vaccination does not require antibody titer monitoring in healthy populations.
  • Universal hepatitis B vaccination is supported by the vaccines' safety and efficacy.
  • Future vaccine developments may further simplify hepatitis B prevention regimens.

Related Experiment Videos